维普中文期刊产品整合服务
7篇 您的检索式:作者名="BALLOT M"
    题名 作者 年代 出处 被引量
1Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicent显示文摘AIM: Anti-Saccharomyces cerevisiae antibodies (ASCA), anti-nuclear associated anti-neutrophil antibodies (NANA) and antibodies to exocrine pancreas (PAB), are serological tools for discriminating Crohn’s disease (CrD) and ulcerative colitis (UC). Like CrD, coeliac disease (CoD) is an inflammatory bowel disease (IBD) associated with (auto) antibodies. Performing a multicenter study we primarily aimed to determine the performance of ASCA, NANA and PAB tests for IBD diagnosis in children and adults, and secondarily to evaluate the prevalence of these markers in CoD. METHODS: Sera of 109 patients with CrD, 78 with UC, 45 with CoD and 50 healthy blood donors were retrospectively included. ASCA, NANA and PAB were detected by indirect immunofluorescence (IIF). RESULTS: ASCA+/NANA- profile displayed a positive predictive value of 94.2% for CrD. Detection of ASCA was correlated with a more severe clinical profile of CrD and treatment of the disease did not influence their serum levels. ASCA positivity was found in 37.9% of active CoD.PAB were found in 36.7% CrD and 13.3% CoD patients and were not correlated with clinical features of CrD, except with an early onset of the disease. Fifteen CrD patients were ASCA negative and PAB positive. CONCLUSION: ASCA and PAB detected by IIF are specific markers for CrD although their presence does not rule out a possible active CoD. The combination of ASCA, NANA and PAB tests improves the sensitivity of immunological markers for CrD. Repeating ASCA, NANA, and PAB testing during the course of CrD has no clinical value.S Desplat-Jégo C Johanet A Escande J Goetz N Fabien N Olsson E Ballot J Sarles JJ Baudon JC Grimaud M Veyrac P Chamouard RL Humbel 2007World Journal of Gastroenterology2007,13,16:24
2Landscape eco- logical assessment: a tool for integrating biodiversity issues in strategic environmental assessment and plan- ning 显示文摘Mortberg U M Ballots B Knol W C 2007Journal of Environmental Management2007,8,2:1
3Exploiting mito- chondrial dysfunction for effective elimination of imatinib - resist- ant leukemic cells显示文摘KLUZA J JENDOUBI M BALLOT C 2011PLoS One2011,6,21:1
4Landscape Ecological Assessment: A Tool for Integrating Biodiversity Issues in Strategic Environmental Assessment and Planning显示文摘Mortberg U M Ballots B Knol W C 2007Journal of Environmental Management2007,82,:1
5All-atom empirical potential for molecular modeling and dynamics studies of proteins显示文摘MACKERELL A D BALLOT M 1998J Phys Chem B1998,102,:1
6A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-] (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer显示文摘O'Connor R O'Leary M Ballot J 2007Cancer Chernother Pharmaco/2007,59,:1
7Landscape ecological assessment: A tool for integrating biodiversity issues in strategic environmental assessment and planning 显示文摘Mortberg U M Ballots B Knol W C 2007Journal of Environmental Management2007,82,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费